loadpatents
name:-0.025187015533447
name:-0.01714301109314
name:-0.00064182281494141
Neuralab Limited Patent Filings

Neuralab Limited

Patent Applications and Registrations

Patent applications and USPTO patent grants for Neuralab Limited.The latest application filed is for "prevention and treatment of amyloidogenic disease".

Company Profile
0.28.36
  • Neuralab Limited - Smiths FL
  • Neuralab Ltd - Athlone IE
  • Neuralab Limited - Flatts BM
  • Neuralab Limited - Flatts Smith NJ
  • Neuralab Limited - BM BM
  • Neuralab Limited - Flatts, Smiths BM
  • Neuralab Limited - Flatts, Smiths FL04 BM
  • Neuralab Ltd -
  • Neuralab Limited - BE BE
  • Neuralab Limited - 102 St. James Court Flatts, Smiths BM
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Prevention And Treatment Of Amyloidogenic Disease
App 20090297511 - Schenk; Dale B.		2009-12-03
Prevention And Treatment Of Amyloidogenic Disease
App 20090191231 - SCHENK; Dale B. ;   et al.		2009-07-30
Humanized antibodies that recognize beta amyloid peptide
Grant 7,189,819 - Basi , et al. March 13, 2		2007-03-13
Humanized antibodies that recognize beta amyloid peptide
Grant 7,179,892 - Basi , et al. February 20, 2		2007-02-20
Humanized antibodies that recognize beta amyloid peptide
App 20060280743 - Basi; Guriq ;   et al.		2006-12-14
Prevention and treatment of amyloidogenic disease
App 20060121038 - Schenk; Dale B. ;   et al.		2006-06-08
Prevention and treatment of amyloidogenic disease
Grant 7,014,855 - Schenk March 21, 2		2006-03-21
Prevention and treatment of amyloidogenic disease
App 20060034858 - Schenk; Dale B.		2006-02-16
Prevention and treatment of amyloidogenic disease
App 20060029611 - Schenk; Dale B.		2006-02-09
Prevention and treatment of amyloidogenic disease
Grant 6,982,084 - Schenk January 3, 2		2006-01-03
Prevention and treatment of amyloidogenic disease
Grant 6,972,127 - Schenk December 6, 2		2005-12-06
Prevention and treatment of amyloidogenic disease
App 20050255122 - Schenk, Dale B.		2005-11-17
Prevention and treatment of amyloidogenic disease
App 20050249727 - Schenk, Dale B.		2005-11-10
Prevention and treatment of amyloidogenic disease
Grant 6,962,707 - Schenk November 8, 2		2005-11-08
Prevention and treatment of amyloidogenic disease
Grant 6,946,135 - Schenk September 20, 2		2005-09-20
Prevention and treatment of amyloidogenic disease
App 20050191292 - Schenk, Dale B.		2005-09-01
Prevention and treatment of amyloidogenic disease
App 20050191314 - Schenk, Dale B.		2005-09-01
Passive immunization of ASCR for prion disorders
Grant 6,936,246 - Schenk August 30, 2		2005-08-30
Active immunization of AScr for prion disorders
Grant 6,923,964 - Schenk August 2, 2		2005-08-02
Prevention and treatment of amyloidogenic disease
App 20050163788 - Schenk, Dale B.		2005-07-28
Prevention and treatment of amyloidogenic disease
App 20050158304 - Schenk, Dale B. ;   et al.		2005-07-21
Passive immunization of Alzheimer's disease
Grant 6,913,745 - Schenk July 5, 2		2005-07-05
Prevention and treatment of amyloidogenic disease
App 20050142132 - Schenk, Dale B. ;   et al.		2005-06-30
Active immunization for treatment of alzheimer's disease
Grant 6,905,686 - Schenk June 14, 2		2005-06-14
Prevention and treatment of amyloidogenic disease
App 20050123544 - Schenk, Dale B. ;   et al.		2005-06-09
Humanized antibodies that recognize beta amyloid peptide
App 20050118651 - Basi, Guriq ;   et al.		2005-06-02
Pharmaceutical compositions and methods for treatment of amyloid diseases
Grant 6,890,535 - Schenk May 10, 2		2005-05-10
Methods of treatment of Alzheimer's disease
Grant 6,875,434 - Schenk April 5, 2		2005-04-05
Prevention and treatment of amyloidogenic disease
App 20050059802 - Schenk, Dale B. ;   et al.		2005-03-17
Prevention and treatment of amyloidogenic disease
App 20050059591 - Schenk, Dale B. ;   et al.		2005-03-17
Prevention and treatment of amyloidogenic disease
Grant 6,866,849 - Schenk March 15, 2		2005-03-15
Prevention and treatment of amyloidogenic disease
Grant 6,866,850 - Schenk March 15, 2		2005-03-15
Prevention and treatment of amyloidogenic disease
App 20050053614 - Schenk, Dale B.		2005-03-10
Prevention and treatment of amyloidogenic disease
App 20050048049 - Schenk, Dale B.		2005-03-03
Prevention And Treatment Of Amyloidogenic Disease
App 20050037026 - Schenk, Dale B.		2005-02-17
Prevention and treatment of amyloidogenic disease
App 20050031629 - Schenk, Dale B.		2005-02-10
Prevention and treatment of amyloidogenic disease
App 20050019328 - Schenk, Dale B.		2005-01-27
Prevention and treatment of amyloidogenic disease
App 20050019330 - Schenk, Dale B.		2005-01-27
Prevention and treatment of amyloidogenic disease
App 20050019343 - Schenk, Dale B.		2005-01-27
Prevention and treatment of amyloidogenic disease
App 20050013815 - Schenk, Dale B.		2005-01-20
Prevention and treatment of amyloidogenic disease
App 20040265308 - Schenk, Dale B.		2004-12-30
Prevention and treatment of amyloidogenic disease
App 20040265301 - Schenk, Dale B. ;   et al.		2004-12-30
Prevention and treatment of amyloidogenic disease
App 20040247590 - Schenk, Dale B. ;   et al.		2004-12-09
Prevention and treatment of amyloidogenic disease
App 20040247591 - Schenk, Dale B. ;   et al.		2004-12-09
Prevention and treatment of amyloidogenic disease
App 20040228865 - Schenk, Dale B.		2004-11-18
Prevention and treatment of amyloidogenic disease
Grant 6,818,218 - Schenk November 16, 2		2004-11-16
Prevention and treatment of amyloidogenic disease
App 20040219146 - Schenk, Dale B.		2004-11-04
Prevention and treatment of amyloidogenic disease
Grant 6,808,712 - Schenk October 26, 2		2004-10-26
Prevention And Treatment Of Amyloidogenic Disease
App 20040175394 - Schenk, Dale B.		2004-09-09
Prevention and treatment of amyloidogenic disease
Grant 6,787,139 - Schenk September 7, 2		2004-09-07
N-Terminal amyloid-.beta. antibodies
Grant 6,787,637 - Schenk September 7, 2		2004-09-07
Prevention and treatment of amyloidogenic disease
Grant 6,787,144 - Schenk September 7, 2		2004-09-07
Prevention and treatment of amyloidogenic disease
Grant 6,787,523 - Schenk September 7, 2		2004-09-07
Prevention and treatment of amyloidogenic disease
Grant 6,787,140 - Schenk September 7, 2		2004-09-07
Prevention and treatment of amyloidogenic disease
Grant 6,787,143 - Schenk September 7, 2		2004-09-07
Prevention and treatment of amyloidogenic disease
Grant 6,787,138 - Schenk September 7, 2		2004-09-07
Prevention And Treatment Of Amyloidogenic Disease
App 20040170641 - Schenk, Dale B.		2004-09-02
Prevention and treatment of amyloidogenic disease
App 20040166119 - Schenk, Dale B.		2004-08-26
Prevention and treatment of amyloidogenic disease
App 20040157779 - Schenk, Dale B.		2004-08-12
Passive immunization treatment of Alzheimer's disease
Grant 6,761,888 - Schenk July 13, 2		2004-07-13
Humanized and chimeric N-terminal amyloid beta-antibodies
Grant 6,750,324 - Schenk , et al. June 15, 2		2004-06-15
Prevention and treatment of amyloidogenic disease
Grant 6,743,427 - Schenk June 1, 2		2004-06-01
Prevention and treatment of amyloidogenic disease
App 20040081657 - Schenk, Dale B.		2004-04-29
Transgenic mouse assay to determine the effect of A.beta. antibodies and A.beta. Fragments on alzheimer's disease characteristics
Grant 6,710,226 - Schenk March 23, 2		2004-03-23
Company Registrations
SEC0001324032Neuralab LTD

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed